Gene expression of Lymphoblastoid Cell Lines–LCLs from Depressed Patients after in-vitro treatment with citalopram–CTP

We used whole gene gene expression profiling to identify potential gene expression biomarkers associated for the treatment individualization of unipolar depression. Gene expression was measured after 24 and 48 hours of in-vitro treatment with 3 µM CTP in n=17 LCLs derived from depressed patients with documented clinical treatment outcome to SSRIs.